Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes

被引：88
作者：
Pitini, V
Arrigo, C
Azzarello, D
La Gattuta, G
Amata, C
Righi, M
Coglitore, S
机构：
来源：
BLOOD | 2003年 / 102卷 / 09期
关键词：
D O I：
10.1182/blood-2003-07-2393
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3456 / 3457
页数：2
相关论文
共 5 条
[1]   Clinical and echocardiographic features of hypereosinophilic Syndromes [J].
Ommen, SR ;
Seward, JB ;
Tajik, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (01) :110-+
[2]   Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders [J].
Pardanani, A ;
Reeder, T ;
Porrata, LF ;
Li, CY ;
Tazelaar, HD ;
Baxter, EJ ;
Witzig, TE ;
Cross, NCP ;
Tefferi, A .
BLOOD, 2003, 101 (09) :3391-3397
[3]   ACTIVATION OF PLATELETS BY EOSINOPHIL GRANULE PROTEINS [J].
ROHRBACH, MS ;
WHEATLEY, CL ;
SLIFMAN, NR ;
GLEICH, GJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) :1271-1274
[4]   Measurement of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: A sensitive non-invasive marker of cardiac disorder [J].
Sato, Y ;
Taniguchi, R ;
Yamada, T ;
Nagai, K ;
Makiyama, T ;
Okada, H ;
Matsumori, A ;
Sasayama, S ;
Takatsu, Y .
INTERNAL MEDICINE, 2000, 39 (04) :350-350
[5]  
Sato Y, 2001, CIRCULATION, V103, P369
1